{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:07:44Z","timestamp":1790276864596,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.bulcan.2016.12.008","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T12:03:08Z","timestamp":1487851388000},"page":"245-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cancers solides apr\u00e8s transplantation d\u2019organe\u00a0: \u00e9pid\u00e9miologie, pronostic et sp\u00e9cificit\u00e9s de prise en charge"],"prefix":"10.1016","volume":"104","author":[{"given":"Aude","family":"Guillemin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Neuzillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Boussion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Grimbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Compagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Duvoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Tournigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2016.12.008_bib0300","series-title":"Synth\u00e8se nationale activit\u00e9 r\u00e9gionale de pr\u00e9l\u00e8vement en 2013","author":"Agence de la biom\u00e9decine","year":"2013"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0305","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Eric","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0310","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/ijc.24439","article-title":"Cancer incidence and risk factors after solid organ transplantation","volume":"125","author":"Vajdic","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0320","series-title":"7e Congr\u00e8s Annuel de la Soci\u00e9t\u00e9 francophone de transplantation","first-page":"97","article-title":"Augmentation du risque de cancer post-greffe dans le registre national des greffes d\u2019organes en France (CRISTAL). Greffes r\u00e9nales, h\u00e9patiques et thoraciques de 1990\u00a0\u00e0 2005","author":"Pessione","year":"2007"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0325","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1470-2045(07)70315-7","article-title":"Management of solid tumours in organ-transplant recipients","volume":"8","author":"Ajithkumar","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/lt.20025","article-title":"De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature","volume":"10","author":"Oruc","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0335","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/S0041-1345(03)00478-0","article-title":"Colorectal cancer after renal transplantation","volume":"35","author":"Saidi","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0340","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1600-6143.2010.03181.x","article-title":"Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit","volume":"10","author":"Collett","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0345","first-page":"177","article-title":"Skin cancer in Caucasian renal allograft recipients living in a subtropical climate","volume":"87","author":"Hardie","year":"1980","journal-title":"Surgery"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0350","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(84)92221-9","article-title":"Cancer, warts, and sunshine in renal transplant patients. A case-control study","volume":"1","author":"Boyle","year":"1984","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0355","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00007890-199003000-00006","article-title":"Incidence of skin cancer after renal transplantation in The Netherlands","volume":"49","author":"Hartevelt","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0360","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00007890-199603150-00008","article-title":"The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study","volume":"61","author":"Bouwes Bavinck","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0365","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1365-2133.2002.04976.x","article-title":"Non-melanoma skin cancer risk in the Queensland renal transplant population","volume":"147","author":"Ramsay","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0370","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.healun.2006.09.009","article-title":"High frequency of bronchogenic carcinoma after single-lung transplantation","volume":"25","author":"Dickson","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0375","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/TP.0b013e3181837761","article-title":"Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation","volume":"86","author":"Hoffmann","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0380","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/sj.jid.5700776","article-title":"Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy","volume":"127","author":"Bouwes Bavinck","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0385","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.TP.0000058744.34965.38","article-title":"Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"75","author":"Vera","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0390","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-6143.2010.03303.x","article-title":"Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients","volume":"11","author":"Goh","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0395","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1148\/radiology.195.3.7753991","article-title":"Prevalence of acquired cystic kidney disease and tumors in native kidneys of renal transplant recipients: a prospective US study","volume":"195","author":"Heinz-Peer","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0400","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0405","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00007890-199802270-00024","article-title":"Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia","volume":"65","author":"Qunibi","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0410","doi-asserted-by":"crossref","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders","volume":"2","author":"Dharnidharka","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0415","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/ajt.12640","article-title":"Adapted treatment of Epstein-Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation","volume":"14","author":"Choquet","year":"2014","journal-title":"Am J Transplant"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.bulcan.2016.12.008_bib0420","first-page":"31","article-title":"European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment","volume":"17","author":"EBPG Expert Group on Renal Transplantation","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0425","series-title":"Vademecum\u00a0: la greffe d\u2019organe en 7\u00a0fiches pratiques","author":"Agence de biom\u00e9decine","year":"2016"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0430","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00007890-200208150-00011","article-title":"Transplant tumor registry: donor related malignancies","volume":"74","author":"Myron Kauffman","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0435","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0041-1345(98)01989-7","article-title":"Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report","volume":"31","author":"Chui","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0440","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","article-title":"Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review","volume":"67","author":"Gutierrez-Dalmau","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0445","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.13786","article-title":"Use of the PD-1\u00a0pathway inhibitor nivolumab in a renal transplant patient with malignancy","author":"Boils","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0450","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0455","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/bjs.1800810718","article-title":"Triple therapy and incidence of de novo cancer in renal transplant recipients","volume":"81","author":"Kehinde","year":"1994","journal-title":"Br J Surg"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0460","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.1114233","article-title":"Azathioprine and UVA light generate mutagenic oxidative DNA damage","volume":"309","author":"O\u2019Donovan","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0465","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3892\/mmr.2014.2302","article-title":"Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4\/SDF-1\u03b1 expression in vivo","volume":"10","author":"Zhu","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0470","first-page":"876","article-title":"Cancers in cyclosporine-treated vs azathioprine-treated patients","volume":"28","author":"Penn","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0475","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/17401","article-title":"Cyclosporine induces cancer progression by a cell-autonomous mechanism","volume":"397","author":"Hojo","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0480","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1054\/bjoc.2001.1931","article-title":"Non-melanoma skin cancers and glucocorticoid therapy","volume":"85","author":"Karagas","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0485","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ajt.12969","article-title":"Sirolimus use and cancer incidence among US kidney transplant recipients","volume":"15","author":"Yanik","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0490","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ajt.12952","article-title":"Five-year outcomes in kidney transplant patients converted from cyclosporine to everolimus: the randomized ZEUS study","volume":"15","author":"Budde","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0495","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/cncr.29324","article-title":"Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients","volume":"121","author":"Shiels","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0500","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jaad.2005.10.049","article-title":"Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series","volume":"54","author":"Harwood","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0505","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/archderm.1986.01660230080015","article-title":"Cutaneous malignant neoplasms in patients with renal transplants","volume":"122","author":"Gupta","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0510","first-page":"459","article-title":"Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants","volume":"137","author":"Otley","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0515","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.transproceed.2014.09.165","article-title":"Incidence and management of Kaposi sarcoma in renal transplant recipients: the Greek experience","volume":"46","author":"Zavos","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0520","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1016\/j.transproceed.2005.10.076","article-title":"Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma","volume":"37","author":"Guti\u00e9rrez-Dalmau","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0525","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi's sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0530","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.transproceed.2004.12.122","article-title":"De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population","volume":"37","author":"Buell","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0535","series-title":"ESMO handbook: cancer treatment in special clinical situations\u00a0\u2013\u00a0Chapter 4: cancer treatment in solid organ transplant recipients","author":"Venugopal","year":"2016"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0540","series-title":"Survie des personnes atteintes de cancer en France, 1989\u20132007","author":"Grosclaude","year":"2007"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0545","series-title":"SEER cancer statistics review, 1975\u20132013","year":"2015"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0550","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1432-2277.2002.tb00199.x","article-title":"A matched case-control study on the prognosis of native kidney neoplasia in renal transplant recipients","volume":"15","author":"Grochowiecki","year":"2002","journal-title":"Transpl Int"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0555","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00007890-199304000-00011","article-title":"The effect of immunosuppression on pre-existing cancers","volume":"55","author":"Penn","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0560","first-page":"14","article-title":"Evaluation of transplant candidates with pre-existing malignancies","volume":"2","author":"Penn","year":"1997","journal-title":"Ann Transplant"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0565","first-page":"853","article-title":"Cancer de la prostate avant transplantation r\u00e9nale\u00a0: \u00e9tude multicentrique","volume":"24","author":"Tillou","year":"2014","journal-title":"Prog Urol"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0570","series-title":"Synth\u00e8se des recommandations professionnelles\u00a0: Suivi ambulatoire de l\u2019adulte transplant\u00e9 r\u00e9nal au-del\u00e0 de 3\u00a0mois apr\u00e8s transplantation","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2007"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0575","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1200\/JCO.2013.51.4067","article-title":"Hepatocellular carcinoma regression after cessation of immunosuppressive therapy","volume":"34","author":"Kumar","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0580","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/ctr.12430","article-title":"Conversion to everolimus dramatically improves the prognosis of de novo malignancies after liver transplantation for alcoholic liver disease","volume":"28","author":"Thimonier","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0585","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archderm.1997.03890380047007","article-title":"External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment","volume":"133","author":"Euvrard","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.bulcan.2016.12.008_bib0295","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6601219","article-title":"Cancer risk following organ transplantation: a nationwide cohort study in Sweden","volume":"89","author":"Adami","year":"2003","journal-title":"Br J Cancer"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455117300036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455117300036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T21:02:18Z","timestamp":1568840538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455117300036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0007455117300036"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2016.12.008","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancers solides apr\u00e8s transplantation d\u2019organe\u00a0: \u00e9pid\u00e9miologie, pronostic et sp\u00e9cificit\u00e9s de prise en charge","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2016.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}